Considerations for Aging Users of GLP-1s Using Sarcopenia as a Case Study
Time: 12:00 pm - 12:30 pm
day: Day One
Details:
- Discussing the potential impact of GLP-1 receptor agonists on sarcopenia in aging populations
- Exploring the complex interplay between GLP-1 signaling, muscle mass, and function
- Examining the potential for GLP-1s to contribute to muscle loss or, conversely, to have beneficial effects on muscle mass and function in older adults
